University of Melbourne-医療機器分野:企業M&A・提携分析

◆英語タイトル:University of Melbourne - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011210
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
The University of Melbourne is an educational service provider that offers graduate, postgraduate, and research degrees. The university offers education in various fields which include arts, engineering, business and economics, architecture, building and planning, land and environment, medical, dentistry, information and technology, education, and health science, law, veterinary science, among others. It also offers awareness and management services to the society in the field of research and teaching services. The university’s health services comprise contraception, sexually transmitted infections, women’s health, men’s health, and others. It also offers research programs. The University of Melbourne is headquartered in Parkville, Victoria, Australia.

University of Melbourne – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of Melbourne, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
University of Melbourne, Medical Equipment Deals By Type, 2011 to YTD 2017 6
University of Melbourne, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
University of Melbourne, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
University of Melbourne, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
University of Melbourne, Medical Equipment, Deal Details 10
Partnerships 10
Genetic Technologies Enters into Licensing Agreement with University of Melbourne 10
University of Melbourne Enters into Licensing Agreement with Transgenomic 11
Peter MacCallum Cancer Centre Enters Into Licensing Agreement With GenoLogics Life Sciences Software For Clarity LIMS 12
Molecular Discovery Enters Into Co Development Agreement With Peter MacCallum Cancer Centre 13
ImmusanT Enters Into Research Agreement With Walter and Eliza Hall Institute of Medical Research 14
Equity Offering 15
Bionic Vision Technologies Raises USD18 Million in Private Placement of Shares 15
University of Melbourne – Key Competitors 17
University of Melbourne – Key Employees 18
University of Melbourne – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Joint Venture 20
Recent Developments 21
Strategy And Business Planning 21
Mar 07, 2016: Expanded Bio21 to house global research hub 21
Product News 22
Jul 06, 2016: Blood test to detect DNA fragments shed from colon cancers predicts disease’s recurrence 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
University of Melbourne, Medical Equipment, Key Facts 2
University of Melbourne, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
University of Melbourne, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
University of Melbourne, Medical Equipment Deals By Type, 2011 to YTD 2017 6
University of Melbourne, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
University of Melbourne, Deals By Market, 2011 to YTD 2017 8
University of Melbourne, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Genetic Technologies Enters into Licensing Agreement with University of Melbourne 10
University of Melbourne Enters into Licensing Agreement with Transgenomic 11
Peter MacCallum Cancer Centre Enters Into Licensing Agreement With GenoLogics Life Sciences Software For Clarity LIMS 12
Molecular Discovery Enters Into Co Development Agreement With Peter MacCallum Cancer Centre 13
ImmusanT Enters Into Research Agreement With Walter and Eliza Hall Institute of Medical Research 14
Bionic Vision Technologies Raises USD18 Million in Private Placement of Shares 15
University of Melbourne, Key Competitors 17
University of Melbourne, Key Employees 18
University of Melbourne, Other Locations 19
University of Melbourne, Subsidiaries 19
University of Melbourne, Joint Venture 20

★海外企業調査レポート[University of Melbourne-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PKB Privatbank SA:企業の戦略・SWOT・財務情報
    PKB Privatbank SA - Strategy, SWOT and Corporate Finance Report Summary PKB Privatbank SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • BDI – BioEnergy International AG:企業の戦略的SWOT分析
    BDI - BioEnergy International AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • ONEOK Partners LP:企業の戦略的SWOT分析
    ONEOK Partners LP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Neovasc Inc (NVC):企業の財務・戦略的SWOT分析
    Summary Neovasc Inc (Neovasc) is a medical device manufacturing company that manufactures, develops, and sells cardiovascular disease products. The company’s products include Neovasc reducer, Neovasc tiara, and Neovasc tissue products. Its Neovasc tiara is a novel transcatheter device that is design …
  • Finox AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Finox AG (Finox), a subsidiary of Richter Gedeon Nyrt, is a drug development and manufacturing company that offers fertility treatment products. The company develops drugs in the field of fertility therapies. Its product portfolio includes biosimilars and patient friendly delivery devices. F …
  • AbbVie Inc (ABBV):企業の財務・戦略的SWOT分析
    AbbVie Inc (ABBV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Mmi Holdings Ltd.:企業の戦略・SWOT・財務分析
    Mmi Holdings Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mmi Holdings Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Shoaibi Group-石油・ガス分野:企業M&A・提携分析
    Summary Shoaibi Group (Shoaibi) is a provider of manufacturing, services, product distribution and investment programs. The company offers active venture capital and private equity investments. It offers services such as marketing and technical services, finance and taxation, public relations, admin …
  • Furukawa Electric Co Ltd (FUWAY):企業の財務・戦略的SWOT分析
    Furukawa Electric Co Ltd (FUWAY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • InVivoScribe Technologies Inc:企業の製品パイプライン分析
    Summary InVivoScribe Technologies Inc (InVivoScribe) is a provider of hematology-oncology testing products and services. The company offer full range of hematology-oncology testing products and services. It’s products include lymphotrack and lymphotrack DX assay kits, and custom assay and reagent de …
  • Addex Therapeutics Ltd (ADXN):製薬・医療:M&Aディール及び事業提携情報
    Summary Addex Therapeutics Ltd (Addex) develops orally available, small molecule allosteric modulators for neurological disorders. The company’s product pipeline consists of its lead products, dipraglurant (mGluR5 negative allosteric modulator or NAM) to treat Parkinson’s disease levodopa-induced dy …
  • ICF International, Inc.:企業の戦略・SWOT・財務情報
    ICF International, Inc. - Strategy, SWOT and Corporate Finance Report Summary ICF International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • United Microelectronics Corporation (2303):企業の財務・戦略的SWOT分析
    United Microelectronics Corporation (2303) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • PDL Biopharma, Inc.:企業の戦略・SWOT・財務情報
    PDL Biopharma, Inc. - Strategy, SWOT and Corporate Finance Report Summary PDL Biopharma, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • EOG Resources, Inc.:企業の戦略・SWOT・財務分析
    EOG Resources, Inc. - Strategy, SWOT and Corporate Finance Report Summary EOG Resources, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Centene Corp (CNC)-製薬・医療分野:企業M&A・提携分析
    Summary Centene Corp (Centene) is a healthcare service provider that offers services to government sponsored healthcare programs with focus on under-insured and uninsured individuals. It provides health plans through Medicaid, Medicare and Health Insurance Marketplace contracts; and other health sol …
  • Aarti Industries Ltd (AARTIIND):企業の財務・戦略的SWOT分析
    Summary Aarti Industries Ltd (Aarti Industries) is a chemical company that manufactures and markets benzene based basic and intermediate chemicals. It offers chemicals, pharma products and surfactants including rubber chemicals, dyes and pigment intermediates; surfactant intermediates, pharmaceutica …
  • Telekom Austria AG (TKA):企業の財務・戦略的SWOT分析
    Telekom Austria AG (TKA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Koninklijke Philips N.V. (PHIA)-医療機器分野:企業M&A・提携分析
    Summary Koninklijke Philips N.V. (Philips) is a diversified technology company which focuses on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. The company develops and manufactures medical …
  • Viscofan, S.A.:企業の戦略・SWOT・財務情報
    Viscofan, S.A. - Strategy, SWOT and Corporate Finance Report Summary Viscofan, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆